| Amy Wicker, OT, LICSW | |
|
101 W 2nd St, Duluth, MN 55802-2086 | |
| (218) 724-3122 | |
| (218) 724-4041 |
| Full Name | Amy Wicker |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 101 W 2nd St, Duluth, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902198088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0019X | Occupational Therapist - Physical Rehabilitation | 103868 (Minnesota) | Secondary |
| 1041C0700X | Social Worker - Clinical | 23668 (Minnesota) | Primary |
| Provider Name | Accend Services Incorporated |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1417023458 PECOS PAC ID: 8224134739 Enrollment ID: O20070430000468 |
News Archive
A new study shows that depressive symptoms are extremely common in people who have obstructive sleep apnea, and these symptoms improve significantly when sleep apnea is treated with continuous positive airway pressure therapy.
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
A new study has uncovered concerning gaps in knowledge about birth control effectiveness.
According to a new report, every year an estimated 8 million children are born with a serious birth defect of genetic or partially genetic origin.
› Verified 9 days ago
| Provider Name | Iron Range Behavioral Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851900484 PECOS PAC ID: 1456756352 Enrollment ID: O20210816001322 |
News Archive
A new study shows that depressive symptoms are extremely common in people who have obstructive sleep apnea, and these symptoms improve significantly when sleep apnea is treated with continuous positive airway pressure therapy.
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
A new study has uncovered concerning gaps in knowledge about birth control effectiveness.
According to a new report, every year an estimated 8 million children are born with a serious birth defect of genetic or partially genetic origin.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Wicker, OT, LICSW 101 W 2nd St, Duluth, MN 55802-2086 Ph: (218) 724-3122 | Amy Wicker, OT, LICSW 101 W 2nd St, Duluth, MN 55802-2086 Ph: (218) 724-3122 |
News Archive
A new study shows that depressive symptoms are extremely common in people who have obstructive sleep apnea, and these symptoms improve significantly when sleep apnea is treated with continuous positive airway pressure therapy.
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
A new study has uncovered concerning gaps in knowledge about birth control effectiveness.
According to a new report, every year an estimated 8 million children are born with a serious birth defect of genetic or partially genetic origin.
› Verified 9 days ago